Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- Long-term cumulative detection of human papillomavirus among HIV seropositive women.AIDS. 2014; 28: 2601-2608
- Squamous cervical lesions in women with human immunodeficiency virus: long-term follow up.Obstet Gynecol. 2008; 111: 1388-1393
- Incidence of cervical precancers among HIV seropositive women.Am J Obstet Gynecol. 2015; 212: 606.e1-606.e8
- Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.J Acquir Immune Defic Syndr. 2013; 62: 405-413
- Long-term incidence of cervical cancer in women with HIV.Cancer. 2009; 115: 524-530
- Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV.J Low Genit Tract Dis. 2007; 11: 90-97
- Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.Int J Cancer. 2007; 121: 621-632
- HPV type 16 and immune status in human immunodeficiency virus seropositive women.J Natl Cancer Inst. 2003; 95: 1062-1072
- Human papillomavirus types among women infected with HIV: a meta-analysis.AIDS. 2006; 20: 2337-2344
- The women’s interagency HIV study.Epidemiology. 1998; 9: 117-125
- The women’s interagency HIV study: an observational cohort brings clinical sciences to the bench.Clin Diag Lab Immunol. 2005; 12: 1013
- Marginal and mixed-effects models in the analysis of human papillomavirus natural history data.Cancer Epidemiol Biomarkers Prev. 2010; 19: 159-169
- Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.Int J Cancer. 2012; 131: 2349-2359
- Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.Gynecol Oncol. 2010; 116: 572-577
- Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India.Vaccine. 2014; 32: 1079-1085
- Distribution of human papillomavirus genotypes among HIV-positive and HIV-negative women in Cape Town, South Africa.Front Oncol. 2014; 4: 48
- Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type.Am J Obstet Gynecol. 2007; 197: 47.e1-47.e8
- Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16.Int J Cancer. 2012; 131: E946-E953
Support for human papillomavirus genotyping and its analysis was provided by R01 CA85178 and R01 CA174634 (Dr Strickler). Clinical data and specimens in this manuscript were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (principal investigators) at New York City/Bronx consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington, DC, metropolitan consortium (Mary Young); the Connie Wofsy study consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California consortium (Alexandra Levine); Chicago consortium (Mardge Cohen); and data coordinating center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases ( UO1-AI-35004 , UO1-AI-31834 , UO1-AI-34994 , UO1-AI-34989 , UO1-AI-34993 , and UO1-AI-42590 ) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development ( UO1-HD-32632 ). The study is co-funded by the National Cancer Institute , the National Institute on Drug Abuse , and the National Institute on Deafness and Other Communication Disorders . Funding is also provided by the National Center for Research Resources (University of California, San Francisco-Clinical & Translational Science Institute grant number UL1 RR024131 ). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. Funders had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Disclosure: Dr Darragh received research supplies for anal cytology and honorarium for a webinar on anal cancer screening from Hologic in October 2012; stock options that ended in August 2014 from OncoHealth advisory board; and honorarium paid to University of California, San Francisco, by Roche in October 2013. A study of Dr Strickler’s involves free blinded testing using human papillomavirus E6/E7 protein assays by Arbor Vita (Fremont, CA), p16/Ki67 cytology by MTM Laboratories/Ventura–Roche (Mannheim, Germany), and MCM-2/TOP2A cytology by BD Diagnostics (Franklin Lakes, NJ). No financial payments to Dr Strickler or his home institution were received. No other authors reported potential financial conflicts of interest.
Cite this article as: Massad LS, Xie X, Burk RD, et al. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol 2016;214:354.e1-6.